FDA Inspection
Sircle Laboratories, L.L.C.Sircle Laboratories, L.L.C. – FDA Inspection, Sep 16, 2022
Record Details
This FDA Inspection record concerns Sircle Laboratories, L.L.C., with an inspection on September 16, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Sircle Laboratories, L.L.C.
- Inspection Date
- September 16, 2022
- Product Type
- Drugs
View Company Profile
ID · 5cb5971d-cf20-4517-a6e8-75739bdb3f48
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1179727
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
5- 21 CFR 211.25(a)Training--operations, GMPs, written procedures
- 21 CFR 211.25(a)GMP Training Frequency
- 21 CFR 211.22(a)Contract drug products--lack of responsibility
- 21 CFR 211.22(d)Procedures not in writing, fully followed
- 21 CFR 211.180(e)(1)Review of representative number of batches
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Sircle Laboratories, L.L.C.
2| Date | Classification | Office | Project area |
|---|---|---|---|
| April 26, 2021 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 19, 2019 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Sircle Laboratories, L.L.C.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.